BDSX
Diagnostics & Research · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Biodesix Inc publishes a filing, an earnings call transcript or a press release.
Get BDSX alertsRobin Harper Cowie is recorded as CFO at Biodesix Inc (BDSX). The proxy statement of Biodesix Inc reports total compensation of $962,001 for Robin Harper Cowie in fiscal 2025, including a base salary of $443,366. Disclosed compensation is on record for 3 fiscal years. Robin Harper Cowie has spoken on 18 earnings calls and 1 other investor event across 1 company, most recently for Biodesix Inc on August 5, 2026. Biodesix Inc is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Biodesix Inc includes Christopher Vazquez (Chief Accounting Officer), Dr. Jon Faiz Kayyem (Board Member) and Lawrence (Lair) T. Kennedy (Board Member).
“Total revenue for the second quarter was $26.9 million, representing a 34% increase over the prior year period. Diagnostic testing revenue was $25.4 million, an increase of 42% year-over-year.”
“Total revenue for the first quarter was $25.6 million, representing a 42% increase over the prior year period. Diagnostic testing revenue was $22.3 million, an increase of 37% year-over-year.”
“Second quarter total revenue was $20.0 million, a 12% increase over the prior year.”
“First quarter total revenue was $18 million, a 21% increase over the prior year.”
BDSX
Diagnostics & Research · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biodesix Inc (BDSX) | Chief Financial Officer, Secretary and Treasurer | $443,366 | $962,001 |
| 2024 | Biodesix Inc (BDSX) | Chief Financial Officer, Secretary and Treasurer | $405,881 | $875,536 |
| 2023 | Biodesix Inc (BDSX) | Chief Financial Officer, Secretary and Treasurer | $355,000 | $844,367 |